Daily News Guess

So in the pharma world today…
$Unilever (UL.US)$ said they won’t bid for $GlaxoSmithKline (GSK.US)$ - share price impact on both? I’d have said lower for Unilever because the acquisition would be good for their fundamentals and the market knows it, GSK down because they miss out on billions. Let’s see

$Sanofi (SNY.US)$ and $Regeneron Pharmaceuticals (REGN.US)$’s Duxipent PRIME 2 study in atopic dermatitis has good data - I guess price goes up

$Zogenix (ZGNX.US)$ to be bought by UCB, surely price will rocket up